Home

undgå National folketælling produktion teva sec filings Ugle køkken porcelæn

DEF 14A
DEF 14A

US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical  Fin Neth 10/01/2026 3.150 Bond
US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Neth 10/01/2026 3.150 Bond

TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical  Industries Ltd. (NYSE) Stock
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock

Teva Investor Relations on the App Store
Teva Investor Relations on the App Store

Teva Pharmaceutical Industries Limited (TEVA) Market Cap (2012-2022) History
Teva Pharmaceutical Industries Limited (TEVA) Market Cap (2012-2022) History

As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech

Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.

DEF 14A
DEF 14A

Teva lures Lundbeck chief Schultz with $52M package that makes him among  pharma's top paid | Fierce Pharma
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid | Fierce Pharma

After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly  $16M | Fierce Pharma
After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly $16M | Fierce Pharma

Form 10-K
Form 10-K

Bank of New York Mellon Corp Increases Investment in Teva Pharmaceutical  Industries Despite Declining Revenue and FDA Warnings - Best Stocks
Bank of New York Mellon Corp Increases Investment in Teva Pharmaceutical Industries Despite Declining Revenue and FDA Warnings - Best Stocks

Teva Gains 6.4% on Another Opioid Case Settlement - TipRanks.com
Teva Gains 6.4% on Another Opioid Case Settlement - TipRanks.com

DEF 14A
DEF 14A

TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical  Industries Ltd. (NYSE) Stock
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock

Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug  Development and Chronic Disease Management with
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with

Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff:  analyst | Fierce Pharma
Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst | Fierce Pharma

Teva Investor Relations on the App Store
Teva Investor Relations on the App Store

DEF 14A
DEF 14A

Assenagon Asset Management S.A. Acquires 121,768 Shares of Teva  Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat
Assenagon Asset Management S.A. Acquires 121,768 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat

DEF 14A
DEF 14A

Stock Forecast Based On a Predictive Algorithm | I Know First |Stock  Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in  Teva Stock
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock

DEF 14A
DEF 14A

DEF 14A
DEF 14A

Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva confirms US FDA warning letter for Hangzhou, China API plant